E2 ModeratePreliminaryPEM unclearCase-ControlPeer-reviewedMachine draft
Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.
Lerner, A Martin, Dworkin, Howard J, Sayyed, Tawfeeq et al. · In vivo (Athens, Greece) · 2004
Quick Summary
This study examined whether certain ME/CFS patients have heart problems caused by incomplete viral infections with Epstein-Barr virus or cytomegalovirus. Researchers found that ME/CFS patients with specific viral antibodies in their blood were more likely to show abnormal heart wall movement compared to control patients without ME/CFS. Some ME/CFS patients even showed heart tissue damage (cardiomyopathy) on biopsy.
Why It Matters
This study provides objective evidence of cardiac dysfunction in a subset of ME/CFS patients and proposes a specific viral mechanism, which could explain exercise intolerance and hemodynamic abnormalities reported by many patients. If confirmed in larger cohorts, this finding might identify a treatable subgroup and help validate ME/CFS as having detectable biological pathology.
Observed Findings
- Abnormal cardiac wall motion at rest was present in 11.5% of ME/CFS patients (10/87) versus 2% of controls (4/191; p=0.0018)
- With exercise stress, 24.1% of ME/CFS patients (21/87) demonstrated abnormal cardiac wall motion
- Diagnostic IgM antibodies to incomplete EBV and/or HCMV viral products were found in ME/CFS patients but absent in 170 control patients in prior blinded studies
- Cardiac biopsies in 3 ME/CFS patients with abnormal wall motion showed histological cardiomyopathy
Inferred Conclusions
- A subset of ME/CFS patients have incomplete EBV and/or HCMV viral multiplication associated with cardiac pathology
- Incomplete herpesvirus replication may cause progressive cardiomyopathy in susceptible ME/CFS patients
- Cardiac wall motion abnormalities in ME/CFS appear more common during exercise stress (24.1%) than at rest (11.5%)
Remaining Questions
- Does incomplete viral replication directly cause the cardiomyopathy, or are both consequences of immune dysfunction?
- What proportion of all ME/CFS patients have this incomplete viral replication pattern and associated cardiac pathology?
- Are there effective antiviral or other treatments that can reverse or slow the cardiac dysfunction in this subset?
What This Study Does Not Prove
This study does not prove that incomplete herpesvirus multiplication causes cardiomyopathy in ME/CFS—it demonstrates association only. The presence of diagnostic antibodies and cardiac wall motion abnormalities may both result from a separate underlying cause rather than one causing the other. Additionally, the findings apply only to the subset of ME/CFS patients with these specific viral antibodies, not all ME/CFS patients.
Tags
Symptom:Fatigue
Biomarker:AutoantibodiesBlood Biomarker
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedWeak Case DefinitionSmall Sample
Metadata
- PMID
- 15369178
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →